Senti Biosciences Stock Analysis

Senti Stock Analysis Notes

About 21.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.67. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Senti Biosciences recorded a loss per share of 15.59. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 18th of July 2024. Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. The company was incorporated in 2016 and is headquartered in South San Francisco, California. Senti Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people. To find out more about Senti Biosciences contact the company at 650 239 2030 or learn more at https://www.sentibio.com.

Senti Biosciences Investment Alerts

Senti Biosciences Upcoming and Recent Events

Senti Largest EPS Surprises

View All Earnings Estimates

Senti Biosciences Environmental, Social, and Governance (ESG) Scores

Senti Stock Institutional Investors

Note, although Senti Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Senti Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 45.89 M.

Senti Profitablity

Management Efficiency

Senti Biosciences has return on total asset (ROA) of (0.3302) % which means that it has lost $0.3302 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1107) %, meaning that it created substantial loss on money invested by shareholders. Senti Biosciences' management efficiency ratios could be used to measure how well Senti Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.57. The current Return On Capital Employed is estimated to decrease to -0.76. As of now, Senti Biosciences' Non Currrent Assets Other are increasing as compared to previous years. The Senti Biosciences' current Total Current Assets is estimated to increase to about 63 M, while Other Assets are projected to decrease to 1.09.

Technical Drivers

As of the 24th of March, Senti Biosciences has the Coefficient Of Variation of (1,638), variance of 43.86, and Risk Adjusted Performance of (0.05). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Senti Biosciences, as well as the relationship between them.

Senti Biosciences Price Movement Analysis

Senti Biosciences Insider Trading Activities

Senti Biosciences Outstanding Bonds

Senti Biosciences Predictive Daily Indicators

Senti Biosciences Corporate Filings

Senti Biosciences Forecast Models

Senti Biosciences' time-series forecasting models are one of many Senti Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Senti Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Senti Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Senti shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Senti Biosciences. By using and applying Senti Stock analysis, traders can create a robust methodology for identifying Senti entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Senti analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Senti analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Senti Biosciences stock analysis indicators help investors evaluate how Senti Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Senti Biosciences shares will generate the highest return on investment. By understating and applying Senti Biosciences stock analysis, traders can identify Senti Biosciences position entry and exit signals to maximize returns.

When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.